Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have a medical reason to take blood-thinning medication called a VKA (vitamin K antagonist, such as warfarin) long-term, and who have already been taking it for more than 6 months.
Who may not be able to join:
- People who do not wish to take part in the study.
- People who have a history of a severe, life-threatening bleeding event or a serious blood clot in the past.
- People who cannot read or write and do not have a caregiver living with them in the same home.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohamed Hosny, MD, Aswan Heart Centre
Phone: +201092565995
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time and proportion of INR in therapeutic range
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.